SOURCE: Implant Sciences Corporation

Implant Sciences Corporation

June 25, 2012 07:00 ET

Implant Sciences Appoints Former Senior Level U.S. Department of State Security Expert as Advisor

WILMINGTON, MA--(Marketwire - Jun 25, 2012) - Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced that Mr. Robert J. Franks has become an Advisor to the Company. Mr. Franks is a highly regarded security expert who has held senior posts with the U.S. Department of State, the U.S. Mission to the United Nations, and private industry. He brings his extensive knowledge of security and law enforcement, along with his relationships with senior-most decision makers at numerous U.S. and international security organizations to Implant Sciences.

Mr. Franks, a 26 year veteran of the U.S. State Department, served as an Assistant Director of the Diplomatic Security Service. While at the Diplomatic Security Service, he also served as Director of International Operations where he managed overseas security and law enforcement for all State Department missions abroad. His responsibilities included operational control over 1,300 Marine Security Guards and all embassy Regional Security Officers. Mr. Franks met regularly with the highest echelons of White House, State Department, Defense Department, and U.S. Intelligence Agencies regarding security matters affecting U.S. foreign policy. He also served as Director of Dignitary Protection, responsible for the protection of the Secretary of State and all foreign dignitaries visiting the United States. Additionally, Mr. Franks served as the Supervisory Regional Security Officer at the U.S. Embassies in Japan and Russia, and Special Assistant for Countermeasure and Information Security at Diplomatic Security Service. Prior to his overseas assignments, he served as a Special Agent with the Diplomatic Security Service for 15 years. Mr. Franks has received numerous awards, honors, and commendations during his years of service from the U.S. Department of State, the U.S. Department of Justice, the FBI, the DEA, and the U.S. Secret Service.

Mr. Franks most recently was employed as an Account Executive with EOD Technology, where he was responsible for overseeing the U.S. Department of State's security support account, a 5-year, multi-billion dollar security services contract. In this role he managed over 700 security specialists assigned to U.S. Embassies. Prior to that, he was Principal Security Advisor to the U.S. Mission to The United Nations where he was responsible for all matters related to the security of foreign missions accredited to the United Nations. During his time in private industry, Mr. Franks served as Director of Corporate Security at Time, Inc., where he was responsible for the company's corporate security program.

"Robert has a keen understanding of the clear benefits our Quantum Sniffers™ offer in multi-layered security environments for both government and corporate security environments. His long-standing relationships with senior staff in federal law enforcement and security personnel at organizations, including the U.S. Department of State, the U.S. Secret Service, and the Department of Homeland Security's Critical Infrastructure, will open doors for the Company," stated Implant Sciences' President and CEO, Glenn D. Bolduc.

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive and narcotics trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and the Company's QS-B220 bench-top explosives and narcotics trace detector has received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the Transportation Security Administration or by other U.S. or foreign government and law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; the risks that our markets are subject to technological change and that our success depends on our ability to develop and introduce new products; that our success depends on our ability to obtain new patents and operate without infringing on the proprietary rights of others; that we may not obtain the patents we have applied for; that the validity and breadth of claims in technology patents involve complex legal and factual questions and, therefore, may be highly uncertain; that any patents we may obtain may be may be challenged and subsequently invalidated, that we may incur substantial costs in asserting our patent rights; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Contact Information

  • Contact:

    Implant Sciences Corporation
    Company Contact:
    Glenn Bolduc
    CEO
    978-752-1700
    Email Contact

    or

    Investor Contact:
    Laurel Moody
    646-810-0608
    Email Contact